Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-15-029906
Filing Date
2015-05-13
Accepted
2015-05-13 08:01:15
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q v409342_10q.htm 10-Q 482036
2 EXHIBIT 31.1 v409342_ex31-1.htm EX-31.1 7619
3 EXHIBIT 31.2 v409342_ex31-2.htm EX-31.2 7676
4 EXHIBIT 32.1 v409342_ex32-1.htm EX-32.1 4285
5 EXHIBIT 32.2 v409342_ex32-2.htm EX-32.2 4306
  Complete submission text file 0001144204-15-029906.txt   4455590

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT capr-20150331.xml EX-101.INS 505069
7 XBRL TAXONOMY EXTENSION SCHEMA capr-20150331.xsd EX-101.SCH 51392
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE capr-20150331_cal.xml EX-101.CAL 31796
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE capr-20150331_def.xml EX-101.DEF 325151
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE capr-20150331_lab.xml EX-101.LAB 343810
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE capr-20150331_pre.xml EX-101.PRE 339460
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Filer) CIK: 0001133869 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34058 | Film No.: 15856459
SIC: 2834 Pharmaceutical Preparations